US4675189A
(en)
*
|
1980-11-18 |
1987-06-23 |
Syntex (U.S.A.) Inc. |
Microencapsulation of water soluble active polypeptides
|
IE52535B1
(en)
*
|
1981-02-16 |
1987-12-09 |
Ici Plc |
Continuous release pharmaceutical compositions
|
US5366734A
(en)
*
|
1981-02-16 |
1994-11-22 |
Zeneca Limited |
Continuous release pharmaceutical compositions
|
DE3218150C2
(de)
*
|
1982-05-14 |
1986-09-25 |
Akzo Gmbh, 5600 Wuppertal |
Wirkstoff enthaltender Körper für die Langzeitabgabe sowie Verfahren zu dessen Herstellung
|
US4489056A
(en)
*
|
1982-06-30 |
1984-12-18 |
Merck & Co., Inc. |
Acid anhydrides as rate controlling agent for the erosion of polymers which latter polymers have beneficial substances dispersed throughout their matrix or where the polymer matrix surrounds the beneficial substance
|
AT382076B
(de)
*
|
1982-10-15 |
1987-01-12 |
Chemie Linz Ag |
Verfahren zur herstellung von presslingen mit retardierter wirkstofffreisetzung
|
CH660488A5
(en)
*
|
1982-12-17 |
1987-04-30 |
Sandoz Ag |
(Co)oligomeric hydroxycarboxylic acid derivatives, the preparation thereof, and the use thereof in pharmaceutical compositions
|
DK119884A
(da)
*
|
1983-03-18 |
1984-09-19 |
Lilly Co Eli |
Fast, cylindrisk, subkutan implantation og dens anvendelse
|
US4649042A
(en)
*
|
1984-05-31 |
1987-03-10 |
Eli Lilly And Company |
Rumen delivery device
|
US4880635B1
(en)
*
|
1984-08-08 |
1996-07-02 |
Liposome Company |
Dehydrated liposomes
|
IE58110B1
(en)
*
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
US4639458A
(en)
*
|
1985-01-22 |
1987-01-27 |
Merck & Co., Inc. |
Tablet and formulation
|
US4670248A
(en)
*
|
1985-08-15 |
1987-06-02 |
International Minerals & Chemical Corp. |
Olivine bolus
|
DE3542972A1
(de)
*
|
1985-12-05 |
1987-06-11 |
Merck Patent Gmbh |
Pharmakadepot
|
DE3543164A1
(de)
*
|
1985-12-06 |
1987-06-19 |
Gmt Medizinische Technik Gmbh |
Knochenzement
|
US4962091A
(en)
*
|
1986-05-23 |
1990-10-09 |
Syntex (U.S.A.) Inc. |
Controlled release of macromolecular polypeptides
|
US4758435A
(en)
*
|
1986-08-11 |
1988-07-19 |
American Cyanamid Company |
Estradiol implant composition and method for preparation
|
DE3710175A1
(de)
*
|
1987-02-12 |
1988-08-25 |
Hoechst Ag |
Mehrteilige implantierbare arzneizubereitung mit langzeitwirkung
|
US5085861A
(en)
*
|
1987-03-12 |
1992-02-04 |
The Beth Israel Hospital Association |
Bioerodable implant composition comprising crosslinked biodegradable polyesters
|
US4843112A
(en)
*
|
1987-03-12 |
1989-06-27 |
The Beth Israel Hospital Association |
Bioerodable implant composition
|
US4897268A
(en)
*
|
1987-08-03 |
1990-01-30 |
Southern Research Institute |
Drug delivery system and method of making the same
|
GB2209937B
(en)
*
|
1987-09-21 |
1991-07-03 |
Depiopharm S A |
Water insoluble polypeptides
|
US4990336A
(en)
*
|
1989-02-08 |
1991-02-05 |
Biosearch, Inc. |
Sustained release dosage form
|
HU221294B1
(en)
*
|
1989-07-07 |
2002-09-28 |
Novartis Ag |
Process for producing retarde compositions containing the active ingredient in a polymeric carrier
|
JPH0374396A
(ja)
*
|
1989-08-16 |
1991-03-28 |
Mercian Corp |
抗菌性組成物
|
FR2654337B1
(fr)
*
|
1989-11-15 |
1994-08-05 |
Roussel Uclaf |
Nouvelles microspheres injectables biodegradables procede de preparation et suspensions injectables les renfermant.
|
US5198220A
(en)
*
|
1989-11-17 |
1993-03-30 |
The Procter & Gamble Company |
Sustained release compositions for treating periodontal disease
|
US5350580A
(en)
*
|
1990-03-05 |
1994-09-27 |
Minnesota Mining And Manufacturing Company |
Device and method for extended delivery of pharmacologically active agents to the ear
|
DE69004415D1
(de)
*
|
1990-03-05 |
1993-12-09 |
Minnesota Mining & Mfg |
Vorrichtung zur verzögerten Abgabe von pharmakologisch aktiven Verbindungen ins Ohr.
|
US6353030B1
(en)
|
1990-08-01 |
2002-03-05 |
Novartis Ag |
Relating to organic compounds
|
IT1243390B
(it)
*
|
1990-11-22 |
1994-06-10 |
Vectorpharma Int |
Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione.
|
US5275820A
(en)
*
|
1990-12-27 |
1994-01-04 |
Allergan, Inc. |
Stable suspension formulations of bioerodible polymer matrix microparticles incorporating drug loaded ion exchange resin particles
|
US5876452A
(en)
*
|
1992-02-14 |
1999-03-02 |
Board Of Regents, University Of Texas System |
Biodegradable implant
|
US6013853A
(en)
*
|
1992-02-14 |
2000-01-11 |
The University Of Texas System |
Continuous release polymeric implant carrier
|
US5296228A
(en)
*
|
1992-03-13 |
1994-03-22 |
Allergan, Inc. |
Compositions for controlled delivery of pharmaceutical compounds
|
US5518730A
(en)
|
1992-06-03 |
1996-05-21 |
Fuisz Technologies Ltd. |
Biodegradable controlled release flash flow melt-spun delivery system
|
US5922340A
(en)
*
|
1992-09-10 |
1999-07-13 |
Children's Medical Center Corporation |
High load formulations and methods for providing prolonged local anesthesia
|
US6913767B1
(en)
|
1993-10-25 |
2005-07-05 |
Genentech, Inc. |
Compositions for microencapsulation of antigens for use as vaccines
|
US5643605A
(en)
*
|
1993-10-25 |
1997-07-01 |
Genentech, Inc. |
Methods and compositions for microencapsulation of adjuvants
|
US6080429A
(en)
*
|
1993-10-25 |
2000-06-27 |
Genentech, Inc. |
Method for drying microspheres
|
CN1058736C
(zh)
*
|
1994-05-27 |
2000-11-22 |
北京市星辰现代控制工程研究所 |
生物降解组合物及其制备方法和应用
|
AU706541B2
(en)
|
1995-06-09 |
1999-06-17 |
Euro-Celtique S.A. |
Formulations and methods for providing prolonged local anesthesia
|
AU717113B2
(en)
|
1995-11-09 |
2000-03-16 |
Health Protection Agency |
Microencapsulated DNA for vaccination and gene therapy
|
US6270795B1
(en)
|
1995-11-09 |
2001-08-07 |
Microbiological Research Authority |
Method of making microencapsulated DNA for vaccination and gene therapy
|
US5747060A
(en)
*
|
1996-03-26 |
1998-05-05 |
Euro-Celtique, S.A. |
Prolonged local anesthesia with colchicine
|
US5817343A
(en)
*
|
1996-05-14 |
1998-10-06 |
Alkermes, Inc. |
Method for fabricating polymer-based controlled-release devices
|
EP0954301A4
(fr)
|
1996-06-24 |
2006-03-08 |
Euro Celtique Sa |
Methodes sures d'anesthesie locale
|
US6046187A
(en)
*
|
1996-09-16 |
2000-04-04 |
Children's Medical Center Corporation |
Formulations and methods for providing prolonged local anesthesia
|
US5783567A
(en)
*
|
1997-01-22 |
1998-07-21 |
Pangaea Pharmaceuticals, Inc. |
Microparticles for delivery of nucleic acid
|
US20020182258A1
(en)
*
|
1997-01-22 |
2002-12-05 |
Zycos Inc., A Delaware Corporation |
Microparticles for delivery of nucleic acid
|
US5912225A
(en)
|
1997-04-14 |
1999-06-15 |
Johns Hopkins Univ. School Of Medicine |
Biodegradable poly (phosphoester-co-desaminotyrosyl L-tyrosine ester) compounds, compositions, articles and methods for making and using the same
|
US5962006A
(en)
*
|
1997-06-17 |
1999-10-05 |
Atrix Laboratories, Inc. |
Polymer formulation for prevention of surgical adhesions
|
US6248345B1
(en)
|
1997-07-02 |
2001-06-19 |
Euro-Celtique, S.A. |
Prolonged anesthesia in joints and body spaces
|
US6375957B1
(en)
|
1997-12-22 |
2002-04-23 |
Euro-Celtique, S.A. |
Opioid agonist/opioid antagonist/acetaminophen combinations
|
HU1500214D0
(hu)
|
1997-12-22 |
2002-03-28 |
Euro Celtique Sa |
Opioid agonista és antagonista hatóanyagot tartalmazó gyógyszerkészítmény
|
CA2318580A1
(fr)
*
|
1998-01-23 |
1999-07-29 |
Mark L. Nelson |
Composes pharmaceutiquement actifs et procedes d'utilisation correspondants
|
GB9810236D0
(en)
|
1998-05-13 |
1998-07-08 |
Microbiological Res Authority |
Improvements relating to encapsulation of bioactive agents
|
US6406719B1
(en)
|
1998-05-13 |
2002-06-18 |
Microbiological Research Authority |
Encapsulation of bioactive agents
|
AU4697099A
(en)
|
1998-06-18 |
2000-01-05 |
Johns Hopkins University School Of Medicine, The |
Polymers for delivery of nucleic acids
|
US6451335B1
(en)
|
1998-07-02 |
2002-09-17 |
Euro-Celtique S.A. |
Formulations and methods for providing prolonged local anesthesia
|
US6143314A
(en)
*
|
1998-10-28 |
2000-11-07 |
Atrix Laboratories, Inc. |
Controlled release liquid delivery compositions with low initial drug burst
|
US20050037086A1
(en)
*
|
1999-11-19 |
2005-02-17 |
Zycos Inc., A Delaware Corporation |
Continuous-flow method for preparing microparticles
|
OA12215A
(en)
|
2000-02-08 |
2006-05-09 |
Euro Celtique Sa |
Tamper-resistant oral opioid agonist formulations.
|
PL357158A1
(en)
|
2000-02-08 |
2004-07-12 |
Euro-Celtique, S.A. |
Controlled-release compositions containing opioid agonist and antagonist
|
WO2001093835A1
(fr)
*
|
2000-06-02 |
2001-12-13 |
Zycos Inc. |
Systemes de distribution d'agents bioactifs
|
DE10031043A1
(de)
|
2000-06-26 |
2002-02-14 |
Bayer Ag |
Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
|
NZ529308A
(en)
*
|
2001-04-05 |
2005-03-24 |
Collagenex Pharm Inc |
Tetracycline compounds comprising a tetracycline and a controlled release agent to provide delivery at a dose below that required for antibiotic activity
|
ES2361148T3
(es)
|
2001-05-11 |
2011-06-14 |
Endo Pharmaceuticals Inc. |
Forma de dosificación de opioides de liberación controlada resistente al abuso.
|
CA2451187C
(fr)
|
2001-06-22 |
2012-08-14 |
Southern Biosystems, Inc. |
Implants coaxiaux a liberation prolongee d'ordre 0
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
US20030044458A1
(en)
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
AU2002324624A1
(en)
|
2001-08-06 |
2003-02-24 |
Euro-Celtique S.A. |
Sequestered antagonist formulations
|
IS7142A
(is)
*
|
2001-08-06 |
2004-02-05 |
Euroceltique S.A. |
Lyfjasamsetningar, sem innihalda morfíngerandaefni, ásamt losanlegu en hömdu mótlyfi
|
EP1482974A4
(fr)
*
|
2002-02-15 |
2006-08-02 |
Zycos Inc |
Procedes d'electroporation pour introduire des agents bioactifs dans des cellules
|
EP2425823A1
(fr)
|
2002-04-05 |
2012-03-07 |
Euro-Celtique S.A. |
Préparation pharmaceutique contenant de l'oxycodone et de la naloxone
|
EP1551372B8
(fr)
|
2002-09-20 |
2018-08-01 |
Alpharma Pharmaceuticals LLC |
Sous-unite de sequestration et compositions et procedes associes
|
CA2505521A1
(fr)
*
|
2002-11-22 |
2004-06-10 |
Meiji Seika Kaisha, Ltd. |
Composition granulaire et son procede de production
|
US7658998B2
(en)
*
|
2003-01-22 |
2010-02-09 |
Alkermes Controlled Therapeutics, Inc. |
Method of preparing sustained release microparticles
|
US9445901B2
(en)
*
|
2003-03-12 |
2016-09-20 |
Deger C. Tunc |
Prosthesis with sustained release analgesic
|
DK1615622T3
(da)
|
2003-04-07 |
2012-10-15 |
Supernus Pharmaceuticals Inc |
Doxycyclinpræparater til indgivelse én gang dagligt
|
TWI347201B
(en)
|
2003-04-21 |
2011-08-21 |
Euro Celtique Sa |
Pharmaceutical products,uses thereof and methods for preparing the same
|
EP1604666A1
(fr)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioides pour le traitement de la bronchopneumopathie chronique obstructive
|
LT1765292T
(lt)
|
2004-06-12 |
2018-01-10 |
Collegium Pharmaceutical, Inc. |
Nuo piktnaudžiavimo apsaugotos vaistų formos
|
US20080031955A1
(en)
*
|
2004-06-30 |
2008-02-07 |
Rijkers Marinus Petrus Wilhelm |
Product Comprising a Beta-Lactam Antibiotic
|
US20060253100A1
(en)
|
2004-10-22 |
2006-11-09 |
Medtronic, Inc. |
Systems and Methods to Treat Pain Locally
|
EP1702558A1
(fr)
|
2005-02-28 |
2006-09-20 |
Euro-Celtique S.A. |
Procédé et dispositif pour évaluer la fonction de l'activité intestinale
|
EP1888101B1
(fr)
|
2005-06-06 |
2012-03-21 |
Georgetown University |
Compositions et procedes de lipomodelage
|
EP2001450B1
(fr)
*
|
2006-03-31 |
2019-01-30 |
Rubicon Research Private Limited |
Mixture directement compressible pour la manufacture des comprimés se désagrégeant dans la cavité orale
|
US20090258028A1
(en)
*
|
2006-06-05 |
2009-10-15 |
Abbott Cardiovascular Systems Inc. |
Methods Of Forming Coatings For Implantable Medical Devices For Controlled Release Of A Peptide And A Hydrophobic Drug
|
US8323676B2
(en)
*
|
2008-06-30 |
2012-12-04 |
Abbott Cardiovascular Systems Inc. |
Poly(ester-amide) and poly(amide) coatings for implantable medical devices for controlled release of a protein or peptide and a hydrophobic drug
|
EP2526932B1
(fr)
|
2006-06-19 |
2017-06-07 |
Alpharma Pharmaceuticals LLC |
Composition pharmaceutique
|
US8017237B2
(en)
|
2006-06-23 |
2011-09-13 |
Abbott Cardiovascular Systems, Inc. |
Nanoshells on polymers
|
WO2008079342A2
(fr)
*
|
2006-12-21 |
2008-07-03 |
Mallinckrodt Inc. |
Comprimés à désintégration par voie orale: composition utilisée et méthode de fabrication orale
|
EP2030613A1
(fr)
*
|
2007-08-17 |
2009-03-04 |
Abbott GmbH & Co. KG |
Préparation de compositions avec essentiellement des antibiotiques macrolides intégrés non cristallins
|
CN101235156B
(zh)
*
|
2007-11-16 |
2011-04-20 |
江苏科技大学 |
一种聚乳酸/热塑性淀粉挤出吹塑薄膜及其生产方法与应用
|
US8623418B2
(en)
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
US8765162B2
(en)
*
|
2008-06-30 |
2014-07-01 |
Abbott Cardiovascular Systems Inc. |
Poly(amide) and poly(ester-amide) polymers and drug delivery particles and coatings containing same
|
MX347106B
(es)
|
2009-03-10 |
2017-04-12 |
Euro-Celtique S A * |
Coposiciones farmacéuticas de liberación inmediata que comprenden oxicodona y naloxona.
|
US8911766B2
(en)
*
|
2009-06-26 |
2014-12-16 |
Abbott Cardiovascular Systems Inc. |
Drug delivery compositions including nanoshells for triggered drug release
|
CA2767646C
(fr)
|
2009-07-10 |
2019-01-29 |
President And Fellows Of Harvard College |
Bloqueurs de canaux sodiques et calciques charges de maniere permanente comme agents anti-inflammatoires
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
US9295663B2
(en)
|
2010-07-14 |
2016-03-29 |
Abbott Cardiovascular Systems Inc. |
Drug coated balloon with in-situ formed drug containing microspheres
|
UA111162C2
(uk)
|
2010-08-04 |
2016-04-11 |
Флекшен Терап'Ютікс, Інк. |
Ін'єкційна композиція ацетоніду триамцинолону для лікування болю
|
WO2012085656A2
(fr)
|
2010-12-22 |
2012-06-28 |
Purdue Pharma L.P. |
Formes pharmaceutiques encapsulées, inviolables et à libération contrôlée
|
KR20140075807A
(ko)
|
2010-12-23 |
2014-06-19 |
퍼듀 퍼머 엘피 |
탬퍼 저항성 고체 경구 투여 형태
|
KR20130124551A
(ko)
|
2011-02-02 |
2013-11-14 |
알파마 파머슈티컬스 엘엘씨 |
오피오이드 효능제 및 격리된 길항제를 포함하는 제약 조성물
|
EP2739287B1
(fr)
|
2011-08-04 |
2017-07-05 |
Flexion Therapeutics, Inc. |
Corticostéroïdes destinés à traiter une douleur articulaire
|
MX2015010041A
(es)
|
2013-02-05 |
2015-10-30 |
Purdue Pharma Lp |
Formulacion farmaceuticas resistentes a la alteracion.
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
CN105517551A
(zh)
|
2013-07-23 |
2016-04-20 |
欧洲凯尔特公司 |
用于在患有疼痛和导致肠生态失调和/或提高肠细菌移位风险之疾病的患者中治疗疼痛的羟考酮与纳洛酮的组合
|
KR20180069782A
(ko)
|
2015-08-03 |
2018-06-25 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
하전 이온 채널 블록커 및 이용 방법
|
US10519442B2
(en)
|
2016-02-11 |
2019-12-31 |
City Of Hope |
Twist signaling inhibitor compositions and methods of using the same
|
EP3429594A1
(fr)
|
2016-03-14 |
2019-01-23 |
Flexion Therapeutics, Inc. |
Formules d'acétonide de triamcinolone pour une douleur articulaire chez les diabétiques
|
US11779657B2
(en)
|
2016-06-10 |
2023-10-10 |
City Of Hope |
Compositions and methods for mitochondrial genome editing
|
WO2017222575A1
(fr)
|
2016-06-23 |
2017-12-28 |
Collegium Pharmaceutical, Inc. |
Procédé de préparation de formulations orales dissuasives d'abus plus stables
|
US10646540B2
(en)
|
2016-11-18 |
2020-05-12 |
City Of Hope |
Peptide inhibitors of twist
|
US11992482B2
(en)
|
2016-12-21 |
2024-05-28 |
Rilento Pharma, Llc |
Malleable controlled release local anesthetic with hemostatic composition
|
US10786485B1
(en)
|
2019-03-11 |
2020-09-29 |
Nocion Therapeutics, Inc. |
Charged ion channel blockers and methods for use
|
US10780083B1
(en)
|
2019-03-11 |
2020-09-22 |
Nocion Therapeutics, Inc. |
Charged ion channel blockers and methods for use
|
EP3937945A4
(fr)
|
2019-03-11 |
2023-01-04 |
Nocion Therapeutics, Inc. |
Bloqueurs de canaux ioniques chargés et procédés d'utilisation
|
JP2022527731A
(ja)
|
2019-03-11 |
2022-06-06 |
ノシオン セラピューティクス,インコーポレイテッド |
エステル置換イオンチャンネル遮断薬および使用方法
|
JP2022527438A
(ja)
|
2019-03-11 |
2022-06-02 |
ノシオン セラピューティクス,インコーポレイテッド |
荷電したイオンチャンネル遮断薬および使用方法
|
BR112022008575A2
(pt)
|
2019-11-06 |
2022-08-09 |
Nocion Therapeutics Inc |
Bloqueadores de canal iônico carregado e métodos para uso
|
JP7513713B2
(ja)
|
2019-11-06 |
2024-07-09 |
ノシオン セラピューティクス,インコーポレイテッド |
荷電したイオンチャンネル遮断薬および使用方法
|
CN115279731A
(zh)
|
2020-03-11 |
2022-11-01 |
诺西恩医疗公司 |
带电的离子通道阻滞剂及其使用方法
|